Congenital Malformations Associated with Maternal Use of Valproic Acid
- 1 August 1987
- journal article
- research article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences
- Vol. 14 (3) , 290-293
- https://doi.org/10.1017/s0317167100026639
Abstract
Two children born with birth defects after intrauterine exposure to valproic acid are reported. The mothers took the drug throughout pregnancy as sole treatment for primary generalized epilepsy. The first baby showed facial dysmorphism, arachnodactyly and triphalangeal thumbs. The second had facial dysmorphism, severe laryngeal hypoplasia, tracheomalacia and an aberrant innominate artery that caused tracheal compression. A left superior vena cava, abnormal pulmonary lobulation, and unilateral hydronephrosis were also found at autopsy. Valproic acid has probable teratogenic potential in humans but the number of reported cases is few and the spectrum of anomalies is broad so it is not possible to delineate a definite fetal valproate syndrome.This publication has 14 references indexed in Scilit:
- IN-UTERO EXPOSURE TO VALPROATE AND NEURAL TUBE DEFECTSThe Lancet, 1986
- Seizure Disorders and PregnancyNew England Journal of Medicine, 1985
- Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsyEuropean Journal of Pharmacology, 1984
- VALPROATE AND BIRTH DEFECTSThe Lancet, 1983
- Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in cultureTeratology, 1983
- Valproic acid and fetal abnormality.BMJ, 1983
- SODIUM VALPROATE AND NEURAL TUBE DEFECTSThe Lancet, 1982
- MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTSThe Lancet, 1982
- Teratogenicity of valproic acidThe Journal of Pediatrics, 1980
- TERATOGENIC POTENTIAL OF VALPROIC ACIDThe Lancet, 1980